Clinical Trials Directory

Trials / Completed

CompletedNCT00067678

Soy Protein in Early Diabetic Nephropathy

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
Sponsor
National Center for Complementary and Integrative Health (NCCIH) · NIH
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Diabetic nephropathy is a frequent cause of end-stage renal disease. Reduction of dietary protein has been used to slow down renal disease progression, but patients are often unwilling to make these dietary changes. Other research suggests that changing the quality of dietary protein may be as effective as reducing the total amount of ingested protein. This study hopes to show that soy protein, a plant protein relatively high in essential amino acids and with high nutritional value, maye be beneficial to Type I diabetic patients with incipient renal disease.

Conditions

Interventions

TypeNameDescription
DRUGsoy protein

Timeline

Start date
2001-07-01
Completion
2003-06-01
First posted
2003-08-27
Last updated
2006-08-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00067678. Inclusion in this directory is not an endorsement.